Labcorp rolls out new blood-based test to diagnose Alzheimer’s disease
Labcorp is offering the new blood-based Amyloid-Tau-Neurodegeneration (ATN) profile test through physicians for use with patients being evaluated…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Oct 23
Labcorp is offering the new blood-based Amyloid-Tau-Neurodegeneration (ATN) profile test through physicians for use with patients being evaluated…
05 Oct 23
AnemoCheck Home is a disposable, in-vitro diagnostic device, designed to help individuals with anaemia due to nutritional deficiency,…
04 Oct 23
Both the therapeutic drug monitoring tests are intended to monitor biologic drugs Humira, Remicade, and their biosimilars at…
29 Sep 23
Harbinger Health intends to use the funds to complete the Cancer ORigin Epigenetics-Harbinger Health 10,000-participant clinical trial of…
25 Sep 23
The Toxin Genetics Test is intended to measure specific genetic biomarkers associated with the body's metabolic detoxification process
20 Sep 23
The T2Biothreat Panel will simultaneously detect six biothreat pathogens including Bacillus anthracis, Francisella tularensis, Burkholderia mallei, Burkholderia pseudomallei,…
11 Sep 23
The non-exclusive licence agreement, which builds on the existing laboratory services agreement between the two companies, allows Plus…
07 Sep 23
The CTS Detachable Dynabeads' active release mechanism uses a release buffer to allow users to actively detach Dynabeads…
05 Sep 23
The license and supply agreement enables ResearchDx to provide high-throughput exosome isolation, biomarker discovery and diagnostics development services…
05 Sep 23
The liquid biopsy company will offer the Portrait Flex assay, which leverages its Parsortix technology, through its Onc-ADaPT…